跳至主要内容
临床试验/NCT01046877
NCT01046877已完成不适用

A Clinical Study of the Acclarent Tympanostomy Tube Delivery System For The Treatment of Patients Requiring Tympanostomy Tube Insertion For Otitis Media

Integra LifeSciences Corporation1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1
主要终点
Percentage of Ears Treated Successfully With the TTDS in the Absence of Acute Intraprocedural Adverse Events.

研究概览

简要总结

The objective of the study is to evaluate the safety and efficacy of the Acclarent Tympanostomy Tube Delivery System (TTDS) in the placement of tympanostomy tubes (TTs) in patients indicated for such treatment for chronic otitis media with effusion (OME) or recurrent acute otitis media (AOM).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >= 1 year of age
  • Diagnosed with either Chronic Otitis Media with Effusion or recurrent Acute Otitis Media and scheduled to undergo bilateral or unilateral tympanostomy tube insertion.
  • Either male or female -

排除标准

  • History of sensitivity or reaction to anaesthesia
  • Markedly atrophic, retracted, atelectatic or perforated tympanic membrane.
  • Otitis externa
  • Active acute otitis media
  • Thickened Tympanic Membrane
  • Thick mucoid effusion (also known as "glue ear")
  • Otitis media pathology requiring T-tubes -

结局指标

主要结局

Percentage of Ears Treated Successfully With the TTDS in the Absence of Acute Intraprocedural Adverse Events.

时间窗: Procedural

TTDS success will be confirmed by the successful delivery of a tube to the tympanic membrane.

次要结局

  • Percentage of Tympanostomy Tubes Extruded at 12 Months Post Procedure(12 months)
  • Percentage of Patent Tubes(9 Months)
  • Percentage of Ears With Adverse Events(12 months post procedure)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验